This Site All Sites

Find a Program

Find a Lab

Bonnie J. and Anthony Addario Endowed Chair in Thoracic Oncology

The newly created Chair in Thoracic Oncology is in honor of thoracic oncologist Thierry Jahan, M.D

Lung Cancer Foundation's Annual Gala on Saturday, Nov. 21, 2009

A benefit for Lung Cancer Research and to celebrate the Addario Lung Cancer Medical Institute.

Make a Gift

A gift to the Thoracic Oncology Progam helps us discover new treatments and cures for lung cancer, esophageal cancer and mesothelioma.

Thoracic Oncology Program »  Our Team »  Sarita Dubey, M.D.

Sarita Dubey, M.D.

Assistant Clinical Professor of Medicine
Department of Medicine, Division of Hematology Oncology

Contact Information

(415) 885-3882 Appointments
(415) 353-7151 Clinic Fax

Education

  • Kilpauk Medical College, Chennai, India MBBS, 1994, Medicine

Residencies

  • Hennepin County Medical Center, Minneapolis, MN, MD, 2001, Internal medicine

Fellowships

  • University of Wisconsin, Madison, WI, 2003, Medical Oncology - NIH (K12) Training Program for Academic Clinical Oncologists

Postdoctoral Training

Board Certification

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Medical Oncology

Program Affiliations

  • Department of Medicine, Division of Hematology Oncology
  • Thoracic Oncology Program
  • Member, UCSF Comprehensive Cancer Center

Clinical Expertise

  • Lung Cancer
  • Mesothelioma
  • Investigational Therapies

Research Interests

  • Trials of targeted agents
  • Gender differences in lung cancer
  • Molecular markers in thoracic malignencies
  • IgF receptor inhibition in non-small cell lung cancer

Website LInks

Interview with U.S. News and World Report
Read article

Biography

Sarita Dubey, M.D. is a medical oncologist who has dedicated her career to the treatment of thoracic malignancies. Dr. Dubey earned her medical degree from Kilpauk Medical College in Madras, India. She then completed a residency in internal medicine at Hennepin County Medical Center and a clinical oncology fellowship at the University of Wisconsin, Madison. At UW, she trained under Dr. Joan Schiller, a world-renowned thoracic oncologist. Following her clinical fellowship, she completed two years of rigorous training in lung cancer research methodology through the UW Academic Oncologist Training Program, part of a prestigious NCI (National Cancer Institute) K12 grant. Dr. Dubey later served as Study Chair on several clinical trials testing novel therapies for non-small cell lung cancer.

Dr. Dubey was recruited to UCSF and joined the faculty there in 2005. The Thoracic Oncology Program then selected her to chair the clinical trials site committee with a mandate to expand the program. In addition to her local leadership at UCSF, Dr. Dubey is a core member of the respiratory committee of CALGB, Cancer and Leukemia Group B, a national clinical research group sponsored by the NCI, and a principal investigator on several CALGB trials. Dr. Dubey's long-term goal is to offer a clinical trial at UCSF for every type and stage of lung cancer and to also address the clinical research needs for less common malignancies such as mesothelioma.

Dr. Dubey has published numerous peer-reviewed articles in the field and regularly presents her work to professional audiences. She is a member of many professional organizations including the American Medical Association (AMA), American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC) and the National Lung Cancer Partnership.

Selected Publications

  1. Dubey S, Powell CA., Update in lung cancer 2006., Am J Respir Crit Care Med. 2007 May 1;175(9):868-74. Review. No abstract available. , PMID: 17446343
  2. Wakelee H, Dubey S, Gandara D., Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease., Oncologist. 2007 Mar;12(3):331-7. Review. , PMID: 17405898
  3. Dubey S, Stephenson P, Levy DE, Miller JA, Keller SM, Schiller JH, Johnson DH, Kolesar JM; Eastern Cooperative Oncology Group., EGFR dinucleotide repeat polymorphism as a prognostic indicator in non-small cell lung cancer., J Thorac Oncol. 2006 Jun;1(5):406-12. , PMID: 17409891
  4. Dubey S, Siegfried JM, Traynor AM., Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond., Lancet Oncol. 2006 May;7(5):416-24. Review. , PMID: 16648046
  5. Dubey S, Hutson P, Alberti D, Arzoomanian R, Binger K, Volkman J, Feierabend C, Wilding G, Schiller JH., Phase I study of docetaxel and topotecan in patients with advanced malignancies., J Oncol Pharm Pract. 2005 Dec;11(4):131-8. , PMID: 16595064

 Email Page  
Send Email to *: (You can include up to four email addresses, separated by a comma)
Your Email Address *:
Email Subject *:
Comment: (maximum of 200 characters)

* required fields
" />